EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer

Noemi Eiro iD, Antonio Medina, Luis O Gonzalez, Maria Fraile iD, Ana Palacios, Safwan Escaf, Jesús M Fernández-Gómez iD, Francisco J Vizoso iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24087022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Noemi Eiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33920 Gijón, Spain. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Intraepithelial Neoplasia, Prostatic Hyperplasia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Usually, after an abnormal level of serum prostate-specific antigen (PSA) or digital rectal exam, men undergo a prostate needle biopsy. However, the traditional sextant technique misses 15–46% of cancers. At present, there are problems regarding disease diagnosis/prognosis, especially in patients’ classification, because the information to be handled is complex and challenging to process. Matrix metalloproteases (MMPs) have high expression by prostate cancer (PCa) compared with benign prostate tissues. To assess the possible contribution to the diagnosis of PCa, we evaluated the expression of several MMPs in prostate tissues before and after PCa diagnosis using machine learning, classifiers, and supervised algorithms. A retrospective study was conducted on 29 patients diagnosed with PCa with previous benign needle biopsies, 45 patients with benign prostatic hyperplasia (BHP), and 18 patients with high-grade prostatic intraepithelial neoplasia (HGPIN). An immunohistochemical study was performed on tissue samples from tumor and non-tumor areas using specific antibodies against MMP -2, 9, 11, and 13, and the tissue inhibitor of MMPs -3 (TIMP-3), and the protein expression by different cell types was analyzed to which several automatic learning techniques have been applied. Compared with BHP or HGPIN specimens, epithelial cells (ECs) and fibroblasts from benign prostate biopsies before the diagnosis of PCa showed a significantly higher expression of MMPs and TIMP-3. Machine learning techniques provide a differentiable classification between these patients, with greater than 95% accuracy, considering ECs, being slightly lower when considering fibroblasts. In addition, evolutionary changes were found in paired tissues from benign biopsy to prostatectomy specimens in the same patient. Thus, ECs from the tumor zone from prostatectomy showed higher expressions of MMPs and TIMP-3 compared to ECs of the corresponding zone from the benign biopsy. Similar differences were found for expressions of MMP-9 and TIMP-3, between fibroblasts from these zones. The classifiers have determined that patients with benign prostate biopsies before the diagnosis of PCa showed a high MMPs/TIMP-3 expression by ECs, so in the zone without future cancer development as in the zone with future tumor, compared with biopsy samples from patients with BPH or HGPIN. Expression of MMP -2, 9, 11, and 13, and TIMP-3 phenotypically define ECs associated with future tumor development. Also, the results suggest that MMPs/TIMPs expression in biopsy tissues may reflect evolutionary changes from prostate benign tissues to PCa. Thus, these findings in combination with other parameters might contribute to improving the suspicion of PCa diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstatic Intraepithelial NeoplasiaProstatic HyperplasiaMaleHumansTissue Inhibitor of Metalloproteinase-3Artificial IntelligenceRetrospective StudiesBiopsyMetalloproteases

Stichwörter der Autor:innen

automatic learning techniquescancer diagnosiscancer-associated fibroblastmatrix metalloproteinasestumor stroma

Substanzen

Tissue Inhibitor of Metalloproteinase-3Metalloproteases

Autor:innen und Institutionen

  • Research Unit, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33920 Gijón, Spain.
  • Department of Anatomical Pathology, Fundación Hospital de Jove, Avda. Eduardo Castro, 161, 33920 Gijón, Spain.
  • Department of Urology, Hospital Universitario Central de Asturias, Universidad de Oviedo, Avda. de Roma s/n, 33011 Oviedo, Spain.

ORCID-Profile: Noemi Eiro, Maria Fraile, Jesús M Fernández-Gómez, Francisco J Vizoso

Zitieren

APA

Eiro, N., Medina, A., Gonzalez, L. O., Fraile, M., Palacios, A., Escaf, S., Fernández-Gómez, J. M., & Vizoso, F. J. (2023). Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087022

Vancouver

Eiro N, Medina A, Gonzalez LO, Fraile M, Palacios A, Escaf S, et al. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087022

BibTeX
@article{Eiro2023,
  author = {Eiro, Noemi and Medina, Antonio and Gonzalez, Luis O and Fraile, Maria and Palacios, Ana and Escaf, Safwan and Fernández-Gómez, Jesús M and Vizoso, Francisco J},
  title = {Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24087022}
}
Kostenlos starten →